Zantac Lawsuit Payouts and Settlement Costs Cause Concerns Among Drug Company Investors
Ahead of the first Zantac lawsuit trials, slated to begin next year, investors sold off Sanofi, GlaxoSmithKline and Pfizer stocks, anticipating massive court losses and costs.